The traditional agents for controlling the levels of glucose in the
blood remain important therapies but they have their downside from
the point of view of tolerability and side effects. Moreover, they
appear not to be able to counter the natural history deterioration
of the disease in terms of the onset of diabetic-related
complications.
Recent years have seen an influx of new treatment therapies and
technologies aimed at achieving better glycaemic control for
diabetic patients such as liraglutide (Novo Nordisk) and
saxagliptin (BMS/Astra-Zeneca) and insulin pumps, away from the
more traditional therapies used (classic insulin therapy, oral
hypoglycaemics).
This book outlines these new technologies/treatments by
collating the best journal articles published in the last year, and
providing expert analysis on each one.
Advanced Technologies and Treatment for Diabetes 3E brings
together and critically analyses the last year's most important
articles published in the world's leading medical journals on this
topic. Chapters are focused on the most current hot topic areas
such as: new methods of insulin delivery; internet and IT use in
treatment of diabetes; bariatric surgery & diabetes; and
immunotherapy for type 1 diabetes.
Each chapter includes abstracts of the published articles,
scientific conclusions made, as well as annotations and a comments
and analysis section from the relevant chapter editor, each of
which being a well-known expert in the field.
All researchers in the fields of diabetes, endocrinology and
metabolism will find this book extremely useful, as will diabetes
technology developers, and specialist endocrinologists involved
with the care of diabetic patients.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!